Pharmaceutical

Filtrer par
OK
NAVELBINE 20MG CAPS. MOLLES B/1
NAVELBINE 20MG CAPS. MOLLES B/1
PIERRE FABRE MEDICAMENT
Details
CANCEROLOGIE
NAVELBINE 30MG CAPS. MOLLES B/1
NAVELBINE 30MG CAPS. MOLLES B/1
PIERRE FABRE MEDICAMENT
Details
CANCEROLOGIE
CISPLATINE MYLAN 1MG/ML (OU 10MG/10ML - 25MG/25ML - 50MG/50ML) SOL. INJ. A DILUER PERF.IV FL./10ML - FL./25ML - FL./50ML
CISPLATINE MYLAN 1MG/ML (OU 10MG/10ML - 25MG/25ML - 50MG/50ML) SOL. INJ. A DILUER PERF.IV FL./10ML - FL./25ML - FL./50ML
MYLAN
Details
CANCEROLOGIE
CISPLATIN EBEWE 0,5MG/ML (25MG/50ML) - (50MG/100ML) CONC.SOL.INJ. PERF. IV B/1FL DE 50 ML - B/1FL. DE 100ML
CISPLATIN EBEWE 0,5MG/ML (25MG/50ML) - (50MG/100ML) CONC.SOL.INJ. PERF. IV B/1FL DE 50 ML - B/1FL. DE 100ML
EBEWE PHARMA
Details
CANCEROLOGIE
CAPEMAX 500MG COMP. PELLI. B/120
CAPEMAX 500MG COMP. PELLI. B/120
INTAS PHARMACEUTICALS LTD
Details
CANCEROLOGIE
XELODA 500MG COMP. PELLI. B/120
XELODA 500MG COMP. PELLI. B/120
ROCHE
Details
CANCEROLOGIE
CAPEGARD 500MG COMP. PELLI. B/10
CAPEGARD 500MG COMP. PELLI. B/10
CIPLA LIMITED
Details
CANCEROLOGIE
HOLOXAN 1G/FL. DE PDRE. PDRE. SOL. INJ. IV B/01FL. DE PDRE. DE CONTENANCE DE 30ML
HOLOXAN 1G/FL. DE PDRE. PDRE. SOL. INJ. IV B/01FL. DE PDRE. DE CONTENANCE DE 30ML
BAXTER
Details
CANCEROLOGIE
ENDOXAN 1G/FL. DE PDRE PDRE. P. SOL. INJ. IV B/01FL. DE PDRE. DE CONTENANCE 75ML
ENDOXAN 1G/FL. DE PDRE PDRE. P. SOL. INJ. IV B/01FL. DE PDRE. DE CONTENANCE 75ML
BAXTER
Details
CANCEROLOGIE
PIRUCIN 2MG/ML (10MG/5ML - 50MG/25ML ET 200MG/100ML) SOL. P. PERF. IV B/01FL. DE 5ML - B/01FL. DE 25ML ET B/01FL. DE 100ML
PIRUCIN 2MG/ML (10MG/5ML - 50MG/25ML ET 200MG/100ML) SOL. P. PERF. IV B/01FL. DE 5ML - B/01FL. DE 25ML ET B/01FL. DE 100ML
HIKMA PHARMACEUTICALS
Details
CANCEROLOGIE
EPINTAS 2MG/ML (10MG/5ML ET 50MG/25ML) SOL. INJ. P. PERF. IV B/01FL. DE 5ML ET B/01FL. DE 25ML
EPINTAS 2MG/ML (10MG/5ML ET 50MG/25ML) SOL. INJ. P. PERF. IV B/01FL. DE 5ML ET B/01FL. DE 25ML
INTAS PHARMACEUTICALS LTD
Details
CANCEROLOGIE
PREXET 500MG/FL. DE PDRE. PDRE. LYOPH. P. SOL. A DILUER P. PERF. IV. B/01 FL. DE PDRE.
PREXET 500MG/FL. DE PDRE. PDRE. LYOPH. P. SOL. A DILUER P. PERF. IV. B/01 FL. DE PDRE.
MUSTAFA NEVZAT
Details
CANCEROLOGIE
ALIMTA 500MG/FL. DE PDRE. PDRE. LYOPH. P. SOL. A DILUER P. PERF. B/01FL. DE PDRE.
ALIMTA 500MG/FL. DE PDRE. PDRE. LYOPH. P. SOL. A DILUER P. PERF. B/01FL. DE PDRE.
ELI LILLY
Details
CANCEROLOGIE
PACLITAX 6MG/ML (30MG/5ML - 100MG/16,5ML - 300MG/50ML) SOL. A DILUER P. PERF. B/1FL/5ML - B/1FL/16,7ML ET B/1FL. DE 50ML
PACLITAX 6MG/ML (30MG/5ML - 100MG/16,5ML - 300MG/50ML) SOL. A DILUER P. PERF. B/1FL/5ML - B/1FL/16,7ML ET B/1FL. DE 50ML
CIPLA LIMITED
Details
CANCEROLOGIE
METHOTREXAT EBEWE 10MG/ML (OU 50MG/5ML) SOL.INJ. B/1FL/5 ML
METHOTREXAT EBEWE 10MG/ML (OU 50MG/5ML) SOL.INJ. B/1FL/5 ML
EBEWE PHARMA
Details
CANCEROLOGIE
METHOTREXATE MYLAN 100MG/ML (1G/10ML - 5G/50ML) SOL. INJ. B/10FL. DE 10ML ET B/10FL DE /50ML
METHOTREXATE MYLAN 100MG/ML (1G/10ML - 5G/50ML) SOL. INJ. B/10FL. DE 10ML ET B/10FL DE /50ML
MYLAN
Details
CANCEROLOGIE
TEMOSIDE 100MG GLES. B/05
TEMOSIDE 100MG GLES. B/05
CIPLA LIMITED
Details
CANCEROLOGIE
TEMOSIDE 250MG GLES. B/05
TEMOSIDE 250MG GLES. B/05
CIPLA LIMITED
Details
CANCEROLOGIE
HOLOXAN 2G/FL. DE PDRE. PDRE. SOL. INJ. IV B/01FL. DE PDRE. DE CONTENANCE DE 50ML
HOLOXAN 2G/FL. DE PDRE. PDRE. SOL. INJ. IV B/01FL. DE PDRE. DE CONTENANCE DE 50ML
BAXTER
Details
CANCEROLOGIE
GEMCITABIN EBEWE 10MG/ML (500MG/50ML) CONC. P. SOL.INJ. P. PERF.IV FL./50ML
GEMCITABIN EBEWE 10MG/ML (500MG/50ML) CONC. P. SOL.INJ. P. PERF.IV FL./50ML
EBEWE PHARMA
Details
CANCEROLOGIE
FLUDARA 10MG COMP. PELLI. FL./20
FLUDARA 10MG COMP. PELLI. FL./20
GENZYME EUROPE BV
Details
CANCEROLOGIE
DOCETAX 120MG/FL. DE CONC. CONC. SOL.INJ. B/1FL. DE CONC. DE 3ML+ 1FL. DE SOLVT. DE 9ML
DOCETAX 120MG/FL. DE CONC. CONC. SOL.INJ. B/1FL. DE CONC. DE 3ML+ 1FL. DE SOLVT. DE 9ML
CIPLA LIMITED
Details
CANCEROLOGIE
VELCADE 3,5MG/FL. DE PDRE. (OU 1MG/ML DE SOL. RECONSTITUEE) PDRE. SOL. INJ. IV B/1FL. DE PDRE. DE CONTENANCE 10ML
VELCADE 3,5MG/FL. DE PDRE. (OU 1MG/ML DE SOL. RECONSTITUEE) PDRE. SOL. INJ. IV B/1FL. DE PDRE. DE CONTENANCE 10ML
JANSSEN CILAG
Details
CANCEROLOGIE
ARASID 100 - ARASID 500 - ARASID 1000 100M/ML (500MG/5ML - 1000MG/10ML) SOL. INJ. P. PERF. IV OU SC B/1FL. DE 1ML - B/1FL. DE 5ML - B/1FL. DE 10ML
ARASID 100 - ARASID 500 - ARASID 1000 100M/ML (500MG/5ML - 1000MG/10ML) SOL. INJ. P. PERF. IV OU SC B/1FL. DE 1ML - B/1FL. DE 5ML - B/1FL. DE 10ML
CPCM
Details
CANCEROLOGIE
ZECYTE 100MG/ML SOL. INJ. IV B/1FL. DE 1ML
ZECYTE 100MG/ML SOL. INJ. IV B/1FL. DE 1ML
CIPLA LIMITED
Details
CANCEROLOGIE
JAVLOR 25MG/ML (50MG/2ML ET 250MG/10ML) SOL. A DILUER P. PERF. IV B/1FL. DE 2ML ET B/1FL. DE 10ML
JAVLOR 25MG/ML (50MG/2ML ET 250MG/10ML) SOL. A DILUER P. PERF. IV B/1FL. DE 2ML ET B/1FL. DE 10ML
PIERRE FABRE MEDICAMENT
Details
CANCEROLOGIE
TEMOSIDE 20MG GLES. B/1PILUL. DE 05
TEMOSIDE 20MG GLES. B/1PILUL. DE 05
CIPLA LIMITED
Details
CANCEROLOGIE
RIBOMUSTIN 2,5MG/ML (APRES RECONSTITUTION) PDRE. P. SOL. A DILIER P. PERF. IV. B/05 FL. DE 25MG -B/01 FL. DE 100MG - B/05 FL. DE 100MG
RIBOMUSTIN 2,5MG/ML (APRES RECONSTITUTION) PDRE. P. SOL. A DILIER P. PERF. IV. B/05 FL. DE 25MG -B/01 FL. DE 100MG - B/05 FL. DE 100MG
ASTELLAS PHARMA
Details
CANCEROLOGIE
JEVTANA 40MG/ML (60MG/1,5ML) SOL. A DILUER ET SOLVANT P./SOL. P./PERF. IV B/01 FL. DE 1,5ML DE SOL. A DILUER + 01 FL. DE 4,5ML DE SOLVANT (ETHANOL 96°, EPPI)
JEVTANA 40MG/ML (60MG/1,5ML) SOL. A DILUER ET SOLVANT P./SOL. P./PERF. IV B/01 FL. DE 1,5ML DE SOL. A DILUER + 01 FL. DE 4,5ML DE SOLVANT (ETHANOL 96°, EPPI)
SANOFI AVENTIS
Details
CANCEROLOGIE
CALCIUM FOLINATE EBEWE 10MG/ML ( 50MG/5ML) SOL. INJ. IM/IV B/5AMP. DE 5ML
CALCIUM FOLINATE EBEWE 10MG/ML ( 50MG/5ML) SOL. INJ. IM/IV B/5AMP. DE 5ML
EBEWE PHARMA
Details
CANCEROLOGIE
Medical Questions
Articles relatifs
Le bilan urodynamique : indications, importance et déroulement de l’examen

Le bilan urodynamique : indications, importance et déroulement de l’examen

La rééducation périnéale : une solution pour retrouver confort et qualité de vie

La rééducation périnéale : une solution pour retrouver confort et qualité de vie

PRP et pathologies musculosquelettiques : quelle place dans la prise en charge ?

PRP et pathologies musculosquelettiques : quelle place dans la prise en charge ?